Protein-protein interaction reveals synergistic discrimination of cancer phenotype

Cancer Informatics

Volumn 9, Issue , 2010, Pages 61-66

  Xiong, Jianghui ^a,b   Liu, Juan ^a   Rayner, Simon ^c   Li, Yinghui ^b   Chen, Shanguang ^b  

^a WUHAN UNIVERSITY   (China)

^b China Astronaut Research and Training Center   (China)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Biomarker; Cancer; Phenotype discrimination; Protein protein interaction

Indexed keywords

CAVEOLIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENTROPY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; HUMAN TISSUE; KERNEL METHOD; NEOPLASM; PARSIMONY ANALYSIS; PHENOTYPE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUPPORT VECTOR MACHINE; ABCB1 GENE; BASE PAIRING; CANX GENE; CAV 1 GENE; CHD3 GENE; CLINICAL ARTICLE; COL10A1 GENE; DATA ACCURACY; EPAS1 GENE; FAM107A GENE; FOCAL ADHESION; GENETIC DISCRIMINATION; LMO2 GENE; LMO4 GENE; LUNG CANCER; MAPK SIGNALING; MAPRE3 GENE; NDEL1 GENE; NOS3 GENE; ONCOGENE; P4HB GENE; PAFAH1B1 GENE; PAICS GENE; PDK1 GENE; PREDICTION; RNA INTERFERENCE; SASH1 GENE; SKIL GENE; SMAD3 GENE; SRC GENE; SSR4 GENE; SYNERGISTIC EFFECT; TCF21 GENE; TNFRSF1B GENE;

EID: 77952905825     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/cin.s3899     Document Type: Article

References (18)

1. Nevins JR, Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet. 2007;8(8):601-9.
2. Wang Y, et al. Gene-expression profiles to predict distant metastasis of lymphnodenegative primary breast cancer. Lancet. 2005;365(9460):671-9.
3. van de Vijver MJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999-2009.
4. Sotiriou C, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262-72.
5. Paik S, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817-26.
6. Yu K, et al. A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res. 2004;64(9):2962-8.
7. Yu JX, et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer. 2007;7:182.
8. Bild AH, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439(7074):353-7.
9. Salter KH, et al. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS ONE. 2008;3(4):e1908.
10. Su LJ, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 2007;8:140.
11. Varadan V, Anastassiou D. Inference of disease-related molecular logic from systems-based microarray analysis. PLoS Comput Biol. 2006;2(6):e68.
12. Statnikov A, et al. GEMS: a system for automated cancer diagnosis and biomarker discovery from microarray gene expression data. Int J Med Inform. 2005;74(7-8):491-503.
13. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005;288(3):C494-506.
14. Williams TM, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem. 2004;279(49):51630-46.
15. Capozza F, et al. Absence of caveolin-1 sensitizes mouse skin to carcinogeninduced epidermal hyperplasia and tumor formation. Am J Pathol. 2003;162(6):2029-39.
16. Engelman JA, et al. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem. 1998;273(32):20448-55.
17. Engelman JA, et al. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J Biol Chem. 1999;274(45):32333-41.
18. Hanczar B, et al. Feature construction from synergic pairs to improve microarray-based classification. Bioinformatics. 2007;23(21):2866-7.